Replimune Group, Inc. beat EPS estimates 40% of the time across 5 reported quarters (2 beats, 3 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q12027 FY2027 | $-0.72 | $-0.72 | +0.0% | Beat |
| Q12027 FY2027 | $-0.72 | $-0.95 | -31.9% | Miss |
| Q42026 FY2026 | $-0.73 | $-0.76 | -4.1% | Miss |
| Q12026 FY2026 | $-0.73 | $-0.82 | -12.3% | Miss |
| Q32026 FY2026 | $-0.85 | $-0.77 | +9.4% | Beat |
Back to REPL overview · REPL holders · REPL KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.